Patient preferences regarding anti-tumor necrosis factor (TNF) therapy among 100 patients in a United Kingdom rheumatology outpatient clinic16. Reprinted from Rheumatology 2006;45:1575–6, with permission.
| Variables | Selecting This As First Choice (%)
| |
|---|---|---|
| Not On Anti-TNF | On Anti-TNF | |
| Administration route | ||
| Subcutaneous | 52.5 | 41 |
| Intramuscular | 30 | 24 |
| Intravenous | 17.5 | 35 |
| Frequency | ||
| Twice Weekly | 2.5 | 2.5 |
| Weekly | 9.5 | 4.5 |
| Monthly | 43 | 22 |
| Two-monthly | 45 | 71 |
| Location | ||
| At home | 52 | 62.5 |
| On a day ward | 36 | 37.5 |
| As an inpatient | 12 | 0 |